Non-alcoholic Steatohepatitis Biomarkers Market Updates by 2031
Non-alcoholic steatohepatitis (NASH) is a type of severe fatty liver disease that is non-alcoholic fatty liver disease (NAFLD). NAFLD is a condition caused due to fat accumulation in the liver and the continuous fat deposition may cause liver inflammation and injury that is known as NASH. NASH can result in scarring of the liver, which is a potentially life-threatening condition known as cirrhosis. The symptoms includes easy bleeding and bruising, itchy skin, jaundice, loss of appetite, nausea, and many more. NASH is more prevalent in patients who are overweight or obese including diabetic, people with elevated cholesterol, inadequate nutrition, polycystic ovary syndrome, and hypothyroidism. Various innovative diagnostic tools are used for accurate diagnosis of the non-alcoholic steatohepatitis condition such as liver biopsy. However, due to high cost of this procedure, various companies have introduced biomarkers as a diagnostic tool for NASH patients such as serum biomarkers, biomarker panels, fibrosis biomarkers, imaging biomarkers, gene biomarkers, and oxidative stress biomarkers.
MARKET SCOPE
The "Global Non-Alcoholic Steatohepatitis Biomarkers Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the non-alcoholic steatohepatitis biomarkers market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading non-alcoholic steatohepatitis biomarkers market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global non-alcoholic steatohepatitis biomarkers market is segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers and others.
- On the basis of application, the market is segmented into pharmaceutical & CRO industry, hospitals, diagnostic labs and academic research institutes.
MARKET DYNAMICS
Drivers
- Rising prevalence of non-alcoholic steatohepatitis (NASH), growing patient pool suffering from diabetes and obesity is driving the non-alcoholic steatohepatitis biomarkers market.
- Increasing patient awareness, growing need for appropriate diagnostic methods and growing demand for noninvasive diagnostic instruments boosts the market growth.
- Growing technological advancements, increasing research and development activities and high prevalence of non-alcoholic fatty liver disease (NAFLD) fuel the market growth.
- Rising advancements in the healthcare infrastructure in developing economies propel the market growth.
Restraints
- Side effects of NASH therapeutics.
- Lack of advanced diagnostic testing for NAFLD.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The non-alcoholic steatohepatitis biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the non-alcoholic steatohepatitis biomarkers market in these regions.
IMPACT OF COVID-19 ON NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The outbreak of novel coronavirus pandemic impacted the growth of the market. It has created major roadblocks for companies which are operating in the non-alcoholic steatohepatitis (NASH) biomarkers market. Due to supply chain disruptions, business shutdown, country-wise lockdown the marketers faced a challenging situation. Companies should now focus on effective business strategies formulation and product diversification in order to overcome the challenges that has aroused during the global pandemic.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The non-alcoholic steatohepatitis biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the non-alcoholic steatohepatitis biomarkers market in these regions.
IMPACT OF COVID-19 ON NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The outbreak of novel coronavirus pandemic impacted the growth of the market. It has created major roadblocks for companies which are operating in the non-alcoholic steatohepatitis (NASH) biomarkers market. Due to supply chain disruptions, business shutdown, country-wise lockdown the marketers faced a challenging situation. Companies should now focus on effective business strategies formulation and product diversification in order to overcome the challenges that has aroused during the global pandemic.
MARKET PLAYERS
The report covers key developments in the non-alcoholic steatohepatitis biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from non-alcoholic steatohepatitis biomarkers market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-alcoholic steatohepatitis biomarkers in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the non-alcoholic steatohepatitis biomarkers market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- BioPredictive
- Cisbio
- Allergan
- NGM Biopharmaceuticals
- AstraZeneca
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Siemens Healthineers
- Genfit
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-alcoholic Steatohepatitis Biomarkers Market - By Type
1.3.2 Non-alcoholic Steatohepatitis Biomarkers Market - By Application
1.3.3 Non-alcoholic Steatohepatitis Biomarkers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SERUM BIOMARKERS
7.3.1. Overview
7.3.2. Serum biomarkers Market Forecast and Analysis
7.4. HEPATIC FIBROSIS BIOMARKERS
7.4.1. Overview
7.4.2. Hepatic fibrosis biomarkers Market Forecast and Analysis
7.5. APOPTOSIS BIOMARKERS
7.5.1. Overview
7.5.2. Apoptosis biomarkers Market Forecast and Analysis
7.6. OXIDATIVE STRESS BIOMARKERS
7.6.1. Overview
7.6.2. Oxidative stress biomarkers Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL AND CRO INDUSTRY
8.3.1. Overview
8.3.2. Pharmaceutical and CRO Industry Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. DIAGNOSTIC LABS
8.5.1. Overview
8.5.2. Diagnostic Labs Market Forecast and Analysis
8.6. ACADEMIC RESEARCH INSTITUTES
8.6.1. Overview
8.6.2. Academic Research Institutes Market Forecast and Analysis
9. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.1.2 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.1.3 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.1.4 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.1.5 North America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.1.1 Canada Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.1.2 Canada Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.1.5.2 Mexico Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.2.1 Mexico Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.2.2 Mexico Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.1.5.3 US Non-alcoholic Steatohepatitis Biomarkers Market
9.1.5.3.1 US Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.1.5.3.2 US Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2. EUROPE
9.2.1 Europe Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.2.2 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.2.3 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.2.4 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.2.5 Europe Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.1.1 Germany Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.1.2 Germany Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.2 France Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.2.1 France Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.2.2 France Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.3 Italy Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.3.1 Italy Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.3.2 Italy Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.4 Spain Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.4.1 Spain Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.4.2 Spain Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.5 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.5.1 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.5.2 United Kingdom Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.2.5.6 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market
9.2.5.6.1 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.2.5.6.2 Rest of Europe Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.3.2 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.1.1 Australia Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.1.2 Australia Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.2 China Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.2.1 China Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.2.2 China Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.3 India Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.3.1 India Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.3.2 India Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.4 Japan Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.4.1 Japan Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.4.2 Japan Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.5 South Korea Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.5.1 South Korea Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.5.2 South Korea Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.3.5.6 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market
9.3.5.6.1 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.3.5.6.2 Rest of Asia-Pacific Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.4.2 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.1.1 South Africa Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.1.2 South Africa Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.2 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.2.1 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.2.2 Saudi Arabia Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.3 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.3.1 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.3.2 U.A.E Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.4.5.4 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market
9.4.5.4.1 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.4.5.4.2 Rest of Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Overview
9.5.2 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Non-alcoholic Steatohepatitis Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.1.1 Brazil Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.1.2 Brazil Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5.5.2 Argentina Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.2.1 Argentina Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.2.2 Argentina Non-alcoholic Steatohepatitis Biomarkers Market by Application
9.5.5.3 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market
9.5.5.3.1 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market by Type
9.5.5.3.2 Rest of South and Central America Non-alcoholic Steatohepatitis Biomarkers Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET, KEY COMPANY PROFILES
11.1. BIOPREDICTIVE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CISBIO
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NGM BIOPHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVO NORDISK A/S
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS HEALTHINEERS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GENFIT
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. BioPredictive
2. Cisbio
3. Allergan
4. NGM Biopharmaceuticals
5. AstraZeneca
6. Novartis AG
7. Novo Nordisk A/S
8. Pfizer, Inc.
9. Siemens Healthineers
10. Genfit
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For